Nuomega's Innovative Neosprout Nasal Hemostatic Sponge Receives FDA Approval for Market Launch

Dec 25, 2024 09:53 CST Updated 09:53

Neo Modulus

Developer of Human Tissue Repair and Organ Regeneration Products

Recently,Neo Modulus' Self-Developed Innovative Medical Device Neosprout Nasal Hemostatic Sponge Receives FDA Approval for Market Launch in the U.S.. As a domestically innovative nasal hemostasis product, the recent approval by the U.S. FDA for market entry strongly demonstrates that Neosprout has achievedInternational High Standards。

Neosprout Nasal Hemostatic Sponge is mainly used for nasal packing hemostasis and postoperative healing. As a "Chinese solution" for new-type nasal packing hemostasis, the Neosprout Nasal Hemostatic Sponge is showcasing China's innovative wisdom and medical contributions to the world with its excellent performance.

Chronic Rhinosinusitis (CRS), as a widespread inflammatory disease of the upper respiratory tract, features a high prevalence rate and significant impact on patients' daily lives, which cannot be ignored. Particularly in Europe and America, the prevalence of CRS is as high as 10.9% to 11.9% and shows an increasing trend. Although Functional Endoscopic Sinus Surgery (FESS) is currently regarded as the preferred treatment for severe CRS, postoperative issues such as wound bleeding, secondary damage caused by hemostatic materials, and adhesions in the surgical cavity are common challenges. Therefore, selecting appropriate nasal packing materials is particularly crucial. Neosprout, an innovative nasal hemostatic sponge, demonstrates remarkable advantages in postoperative hemostasis and wound management for CRS due to its unique expandability, biodegradability, and shape memory properties. Neosprout not only provides clinicians with a superior treatment option but also delivers better therapeutic outcomes and postoperative experiences for patients.

Meanwhile, with its outstanding product performance and innovative strength, Neosprout Nasal Hemostatic Sponge has successfully obtained MDR CE certification. The approval of this product by the U.S. FDA for marketing marks a further improvement in Neo Modulus’ global strategic layout. Neo Modulus will always keep moving forward, adhering to the concept of "innovation and internationalization," continuously advancing its internationalization process, expanding overseas markets, and promoting more "China solutions" related to medical devices worldwide, contributing more Chinese wisdom and strength to the world.

About FDA

The U.S. Food and Drug Administration (FDA) is a government agency responsible for promoting and protecting public health. The FDA was established with the passage of the Pure Food and Drugs Act in 1906. The agency has different departments that oversee most of its obligations involving food, drugs, cosmetics, animal food, dietary supplements, medical devices, biological products, and blood products.

Statement:

This article is for news purposes only, and its content is solely intended for information dissemination or industry exchange. No content herein should be regarded as advertising or representing any explicit or implied advertisement, nor should it be considered as having any purpose related to sales or promises of sales. For precise information, the audience is advised to consult professional medical institutions and seek expert opinions.

If any individual or media outlet, website wishes to reprint this article, please contact the official account for authorization and indicate the source of the reprint.